Frederick W. Driscoll
2015 - Flexion Therapeutics
In 2015, Frederick W. Driscoll earned a total compensation of $1.4M as Chief Financial Officer at Flexion Therapeutics, a 59% increase compared to previous year.
Compensation breakdown
| Bonus | $107,730 |
|---|---|
| Option Awards | $916,400 |
| Salary | $324,000 |
| Other | $24,249 |
| Total | $1,372,379 |
Driscoll received $916.4K in option awards, accounting for 67% of the total pay in 2015.
Driscoll also received $107.7K in bonus, $324K in salary and $24.2K in other compensation.
Rankings
In 2015, Frederick W. Driscoll's compensation ranked 6,417th out of 13,638 executives tracked by ExecPay. In other words, Driscoll earned more than 52.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,417 out of 13,638 | 53rd |
Division Manufacturing | 2,405 out of 5,187 | 54th |
Major group Chemicals And Allied Products | 872 out of 1,857 | 53rd |
Industry group Drugs | 697 out of 1,531 | 55th |
Industry Pharmaceutical Preparations | 544 out of 1,179 | 54th |
Source: SEC filing on April 28, 2017.
Driscoll's colleagues
We found two more compensation records of executives who worked with Frederick W. Driscoll at Flexion Therapeutics in 2015.